This article is more than 5 years old. Information may no longer be current.
AACR establishes immunology award
The American Association for Cancer Research and the Cancer Research Institute established the Lloyd J. Old Award in Cancer Immunology.
Lloyd J. Old
The award honors the memory of Lloyd J. Old, MD, who was internationally recognized as the “Father of Modern Tumor Immunology.” Old, whose career began in 1958, held positions at several institutions, including Memorial Sloan-Kettering Cancer Center and Ludwig Institute for Cancer Research. He died on Nov. 28, 2011.
“The AACR is honored to collaborate with the Cancer Research Institute and offer this award in honor of Dr. Old,” Margaret Foti, PhD, MD, CEO of AACR, said in a press release. “Dr. Old’s vision and leadership brought basic and clinical investigators together, across both institutional and international borders, to take tumor immunology from animal models into clinical research and develop promising new cancer therapies.”
The recipient will receive a $10,000 honorarium, support to attend the AACR Annual Meeting in April and an invitation to give a 50-minute lecture during the meeting.
“Dr. Old’s prescient vision for the future of cancer treatment was rooted in his unwavering belief that the study of the immune system would ultimately yield the key to providing cancer patients with new and lifesaving treatment options,” said Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at CRI. “Many of Dr. Old’s own important discoveries laid the foundation for today’s successes in clinical cancer immunotherapy.”